ARTG 179630Dialysate, haemodialysis
ARTG ID: 179630 · Fresenius Medical Care Australia Pty Ltd · NxStage Medical Inc · Class IIb · Started February 01, 2011
Good Name: Fresenius Medical Care Australia Pty Ltd - Dialysate, haemodialysis
- Risk Class
- Class IIb
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 179630
- Start Date
- February 01, 2011
- Effective Date
- February 01, 2011
- Country
- United States of America
- Address
- 350 Merrimack Street, Lawrence, MA, 01843
A premixed solution used in dialysis treatment and which is prepared for the exchange of solutes across a semi-permeable membrane, to assist in the removal of toxic waste products without the loss of essential electrolytes and excessive water depletion.
Access comprehensive regulatory information for Dialysate, haemodialysis in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 179630 and sponsored by Fresenius Medical Care Australia Pty Ltd, manufactured by NxStage Medical Inc in United States of America. The device registration started on February 01, 2011.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.